Daprodustat
| CAS No. | 960539-70-2 |
|---|---|
| MDL No. | N/A |
| MF | C19H27N3O6 |
| MW | 393.40 |
| InChI Key | RUEYEZADQJCKGV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Daprodustat is a barbiturate derived from barbituric acid, substituted with cyclohexyl groups at positions 1 and 3, and a (carboxymethyl)aminocarbonyl group at position 5. It is an inhibitor of hypoxia-inducible factor prolyl hydroxylase, developed by GlaxoSmithKline for the treatment of anaemia in patients with chronic kidney disease. It functions as an anti-anaemic agent, an EC 1.14.11.29 inhibitor, and an antiviral agent. It belongs to the classes of barbiturates, secondary carboxamides, N-acylglycine, and oxo monocarboxylic acids.
| CAS No. | 960539-70-2 |
|---|---|
| Product Name | Daprodustat |
Biological Targets
EGLN2·P4HTM·EGLN1·EGLN3
Associated Conditions
chronic kidney disease·peripheral vascular disease·injury·anemia·anemia (phenotype)
* The information provided here is compiled from public sources and is for reference only.